Bilaketaren emaitzak - Spitzer, Barbara

Toward More Complete Prognostication for Patients with Clonal Hematopoiesis nork Spitzer, Barbara, Levine, Ross L.

Testu osoa Testu osoa Testu osoa

Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia nork Ramaswamy, Kavitha, Spitzer, Barbara, Kentsis, Alex

Testu osoa Testu osoa Testu osoa

Genetic alterations of the cohesin complex genes in myeloid malignancies nork Thota, Swapna, Viny, Aaron D., Makishima, Hideki, Spitzer, Barbara, Radivoyevitch, Tomas, Przychodzen, Bartlomiej, Sekeres, Mikkael A., Levine, Ross L., Maciejewski, Jaroslaw P.

Testu osoa Testu osoa Testu osoa

Early CD4+ T cell reconstitution as Predictor for Outcomes after Allogenic Hematopoietic Cell Transplantation nork van Roessel, Ichelle, Prockop, Susan, Klein, Elizabeth, Boulad, Farid, Scaradavou, Andromachi, Spitzer, Barbara, Kung, Andrew, Curran, Kevin, O’Reilly, Richard, Kernan, Nancy, Cancio, Maria, Boelens, Jaap Jan

Testu osoa Testu osoa Testu osoa

ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML nork Spitzer, Barbara, Dela Cruz, Filemon S., Ibanez Sanchez, Glorymar D., Zhang, Yanming, Xiao, Wenbin, Benayed, Ryma, Markova, Alina, Rodriguez-Sanchez, M. Irene, Bouvier, Nancy, Roshal, Mikhail, Kung, Andrew L., Shukla, Neerav

Testu osoa Testu osoa Testu osoa

Second allogeneic stem cell transplantation for acute leukemia using a chemotherapy only cytoreduction with clofarabine, melphalan, and thiotepa nork Spitzer, Barbara, Perales, Miguel-Angel, Kernan, Nancy A., Prockop, Susan E., Zabor, Emily C., Webb, Nicholas, Castro-Malaspina, Hugo, Papadopoulos, Esperanza B., Young, James W., Scaradavou, Andromachi, Kobos, Rachel, Giralt, Sergio A., O'Reilly, Richard J, Boulad, Farid

Testu osoa Testu osoa Testu osoa

Deletions linked to TP53 loss drive cancer through p53–independent mechanisms nork Liu, Yu, Chen, Chong, Xu, Zhengmin, Scuoppo, Claudio, Rillahan, Cory D., Gao, Jianjiong, Spitzer, Barbara, Bosbach, Benedikt, Kastenhuber, Edward R., Baslan, Timour, Ackermann, Sarah, Cheng, Lihua, Wang, Qingguo, Niu, Ting, Schultz, Nikolaus, Levine, Ross L., Mills, Alea A., Lowe, Scott W.

Testu osoa Testu osoa Testu osoa

Low Toxicity and Favorable Overall Survival in Relapsed/Refractory B-ALL following CAR T cells and CD34-selected T Cell Depleted Allogeneic Hematopoietic Cell Transplant. nork Fabrizio, Vanessa A., Kernan, Nancy A., Boulad, Farid, Cancio, Maria, Allen, Jennifer, Higman, Meghan, Margossian, Steven P., Mauguen, Audrey, Prockop, Susan, Scaradavou, Andromachi, Shah, Niketa, Spitzer, Barbara, Stieglitz, Elliot, Yeager, Nicholas, O’Reilly, Richard J., Brentjens, Renier J., Boelens, Jaap Jan, Curran, Kevin J.

Testu osoa Testu osoa Testu osoa

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms nork Rampal, Raajit K., Pinzon-Ortiz, Maria, Somasundara, Amritha Varshini Hanasoge, Durham, Benjamin, Koche, Richard, Spitzer, Barbara, Mowla, Shoron, Krishnan, Aishwarya, Li, Bing, An, Wenbin, Derkach, Andriy, Devlin, Sean, Rong, Xianhui, Longmire, Tyler, Eisman, Shira Esther, Cordner, Keith, Whitfield, Justin T., Vanasse, Gary, Cao, Alexander, Levine, Ross L.

Testu osoa Testu osoa Testu osoa

A Chemotherapy-only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of... nork Spitzer, Barbara, Jakubowski, Ann A., Papadopoulos, Esperanza B., Fuller, Kirsten, Hilden, Patrick D., Young, James W., Barker, Juliet, Koehne, Guenther, Perales, Miguel-Angel, Hsu, Katharine C., van den Brink, Marcel R.M., Kernan, Nancy A, Prockop, Susan E., Scaradavou, Andromachi, Castro-Malaspina, Hugo, O'Reilly, Richard J., Boulad, Farid

Testu osoa Testu osoa Testu osoa

CD4(+) T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation nork de Koning, Coco, Prockop, Susan, van Roessel, Ichelle, Kernan, Nancy, Klein, Elizabeth, Langenhorst, Jurgen, Szanto, Celina, Belderbos, Mirjam, Bierings, Marc, Boulad, Farid, Bresters, Dorine, Cancio, Maria, Curran, Kevin, Kollen, Wouter, O’Reilly, Richard, Scaradavou, Andromachi, Spitzer, Barbara, Versluijs, Birgitta, Huitema, Alwin, Lindemans, Caroline, Nierkens, Stefan, Boelens, Jaap Jan

Testu osoa Testu osoa Testu osoa

Dnmt3a Regulates Myeloproliferation and Liver-Specific Expansion of Hematopoietic Stem and Progenitor Cells nork Guryanova, Olga A., Lieu, Yen K., Garrett-Bakelman, Francine E., Spitzer, Barbara, Glass, Jacob L., Shank, Kaitlyn, Valencia Martinez, Ana Belen, Rivera, Sharon A., Durham, Benjamin H., Rapaport, Franck, Keller, Matthew D., Pandey, Suveg, Bastian, Lennart, Tovbin, Daniel, Weinstein, Abby R., Teruya-Feldstein, Julie, Abdel-Wahab, Omar, Santini, Valeria, Mason, Christopher E., Melnick, Ari M., Mukherjee, Siddhartha, Levine, Ross L.

Testu osoa Testu osoa Testu osoa

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition nork McKenney, Anna Sophia, Lau, Allison N., Somasundara, Amritha Varshini Hanasoge, Spitzer, Barbara, Intlekofer, Andrew M., Ahn, Jihae, Shank, Kaitlyn, Rapaport, Franck T., Patel, Minal A., Papalexi, Efthymia, Shih, Alan H., Chiu, April, Freinkman, Elizaveta, Akbay, Esra A., Steadman, Mya, Nagaraja, Raj, Yen, Katharine, Teruya-Feldstein, Julie, Wong, Kwok-Kin, Rampal, Raajit, Heiden, Matthew G. Vander, Thompson, Craig B., Levine, Ross L.

Testu osoa Testu osoa Testu osoa

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition nork McKenney, Anna Sophia, Lau, Allison N., Somasundara, Amritha Varshini Hanasoge, Spitzer, Barbara, Intlekofer, Andrew M., Ahn, Jihae, Shank, Kaitlyn, Rapaport, Franck T., Patel, Minal A., Papalexi, Efthymia, Shih, Alan H., Chiu, April, Freinkman, Elizaveta, Akbay, Esra A., Steadman, Mya, Nagaraja, Raj, Yen, Katharine, Teruya-Feldstein, Julie, Wong, Kwok-Kin, Rampal, Raajit, Vander Heiden, Matthew G., Thompson, Craig B., Levine, Ross L.

Testu osoa Testu osoa Testu osoa

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL nork Curran, Kevin J., Margossian, Steven P., Kernan, Nancy A., Silverman, Lewis B., Williams, David A., Shukla, Neerav, Kobos, Rachel, Forlenza, Christopher J., Steinherz, Peter, Prockop, Susan, Boulad, Farid, Spitzer, Barbara, Cancio, Maria I., Boelens, Jaap Jan, Kung, Andrew L., Szenes, Victoria, Park, Jae H., Sauter, Craig S., Heller, Glenn, Wang, Xiuyan, Senechal, Brigitte, O’Reilly, Richard J., Riviere, Isabelle, Sadelain, Michel, Brentjens, Renier J.

Testu osoa Testu osoa Testu osoa

Acid ceramidase is upregulated in AML and represents a novel therapeutic target nork Tan, Su-Fern, Liu, Xin, Fox, Todd E., Barth, Brian M., Sharma, Arati, Turner, Stephen D., Awwad, Andy, Dewey, Alden, Doi, Kenichiro, Spitzer, Barbara, Shah, Mithun Vinod, Morad, Samy A.F., Desai, Dhimant, Amin, Shantu, Zhu, Junjia, Liao, Jason, Yun, Jong, Kester, Mark, Claxton, David F., Wang, Hong-Gang, Cabot, Myles C., Schuchman, Edward H., Levine, Ross L., Feith, David J., Loughran, Thomas P.

Testu osoa Testu osoa Testu osoa

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation nork Lakkaraja, Madhavi, Scordo, Michael, Mauguen, Audrey, Cho, Christina, Devlin, Sean, Ruiz, Josel D., Klein, Elizabeth, Avecilla, Scott T., Boulad, Farid, Cancio, Maria I., Curran, Kevin J., Jakubowski, Ann A., Kernan, Nancy A., Kung, Andrew L., O’Reilly, Richard J., Papadopoulos, Esperanza B., Prockop, Susan, van Roessel, Ichelle, Scaradavou, Andromachi, Shaffer, Brian C., Shah, Gunjan, Spitzer, Barbara, Tamari, Roni, Giralt, Sergio A., Perales, Miguel-Angel, Boelens, Jaap Jan

Testu osoa Testu osoa Testu osoa

Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis nork Gao, Teng, Ptashkin, Ryan, Bolton, Kelly L., Sirenko, Maria, Fong, Christopher, Spitzer, Barbara, Menghrajani, Kamal, Ossa, Juan E. Arango, Zhou, Yangyu, Bernard, Elsa, Levine, Max, Martinez, Juan S. Medina, Zhang, Yanming, Franch-Expósito, Sebastià, Patel, Minal, Braunstein, Lior Z., Kelly, Daniel, Yabe, Mariko, Benayed, Ryma, Caltabellotta, Nicole M., Philip, John, Paraiso, Ederlinda, Mantha, Simon, Solit, David B., Diaz, Luis A., Berger, Michael F., Klimek, Virginia, Levine, Ross L., Zehir, Ahmet, Devlin, Sean M., Papaemmanuil, Elli

Testu osoa Testu osoa Testu osoa

MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia nork Brown, Fiona C., Still, Eric, Koche, Richard P., Yim, Christina Y., Takao, Sumiko, Cifani, Paolo, Reed, Casie, Gunasekera, Shehana, Ficarro, Scott B., Romanienko, Peter, Mark, Willie, McCarthy, Craig, de Stanchina, Elisa, Gonen, Mithat, Seshan, Venkatraman, Bhola, Patrick, O’Donnell, Conor, Spitzer, Barbara, Stutzke, Crystal, Lavallée, Vincent-Philippe, Hébert, Josée, Krivtsov, Andrei V., Melnick, Ari, Paietta, Elisabeth M., Tallman, Martin S., Letai, Anthony, Sauvageau, Guy, Pouliot, Gayle, Levine, Ross, Marto, Jarrod A, Armstrong, Scott A., Kentsis, Alex

Testu osoa Testu osoa Testu osoa

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation nork Prockop, Susan, Doubrovina, Ekaterina, Suser, Stephanie, Heller, Glenn, Barker, Juliet, Dahi, Parastoo, Perales, Miguel A., Papadopoulos, Esperanza, Sauter, Craig, Castro-Malaspina, Hugo, Boulad, Farid, Curran, Kevin J., Giralt, Sergio, Gyurkocza, Boglarka, Hsu, Katharine C., Jakubowski, Ann, Hanash, Alan M., Kernan, Nancy A., Kobos, Rachel, Koehne, Guenther, Landau, Heather, Ponce, Doris, Spitzer, Barbara, Young, James W., Behr, Gerald, Dunphy, Mark, Haque, Sofia, Teruya-Feldstein, Julie, Arcila, Maria, Moung, Christine, Hsu, Susan, Hasan, Aisha, O’Reilly, Richard J.

Testu osoa Testu osoa Testu osoa